UK Companies House feature
THE NEW FOSCOTE HOSPITAL LIMITED
Cash
£109K
-49.4% vs 2024
Net assets
£1M
+29% vs 2024
Employees
105
-12.5% vs 2024
Profit before tax
£465K
+60.4% vs 2024
Profile
- Company number
- 11742951
- Status
- Active
- Incorporation
- 2018-12-28
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 86101
- Hubs
- UK Healthcare
Net assets
9-year trend · vs UK Healthcare median
Accounts
9-year trend · latest 2025-03-31
| Metric | Trend | 2020-03-31 | 2021-03-31 | 2021-04-01 | 2022-03-31 | 2022-04-01 | 2023-03-31 | 2023-04-01 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | £5,944,594 | — | £6,875,219 | — | £7,509,093 | £9,185,862 | |
| Operating profit | — | — | — | £334,172 | — | £206,115 | — | £307,069 | £476,202 | |
| Profit before tax | — | — | — | £327,839 | — | £184,023 | — | £289,792 | £464,903 | |
| Net profit | — | — | — | £290,839 | — | £168,023 | — | £143,792 | £232,903 | |
| Cash | £108,012 | £635,688 | — | £79,166 | — | £186,438 | — | £215,389 | £108,933 | |
| Total assets less current liabilities | £1,189,647 | £2,114,306 | — | £2,785,921 | — | £2,849,499 | — | £1,311,816 | £1,642,918 | |
| Net assets | £649,353 | £200,306 | — | £491,145 | — | £659,168 | — | £802,960 | £1,035,863 | |
| Equity | £649,353 | £200,306 | £200,306 | £491,145 | £491,145 | £659,168 | £659,168 | £802,960 | £1,035,863 | |
| Average employees | 68 | 80 | — | 99 | — | 120 | — | 120 | 105 | |
| Wages | — | — | — | £2,129,850 | — | — | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Sumer Auditco Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “The Hospital has increased its outpatient and diagnostic capacity to attract new consultants with specialised, demand-driven, capabilities. In addition, the Hospital has built a second operating theatre to meet the increased demand and, it has also built a Theatre Sterile Service Unit to improve the turnaround of surgical instruments, to increase efficiency.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
1 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| SHAKIB, Kaveh | Director | 2018-12-28 | Aug 1971 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Foscote Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-03-07 | Active |
| Mr Kaveh Shakib | Individual | Shares 50–75%, Voting 50–75%, Appoints directors | 2018-12-28 | Ceased 2019-03-07 |
Filing timeline
Last 20 of 21 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-24 | AA | accounts | accounts with accounts type full |
| 2026-03-23 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-03-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-12-23 | AA | accounts | accounts with accounts type full |
| 2024-03-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-12-21 | AA | accounts | accounts with accounts type full |
| 2023-03-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-12-20 | AA | accounts | accounts with accounts type total exemption full |
| 2022-03-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-02-08 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2022-02-01 | CH01 | officers | change person director company with change date |
| 2021-12-13 | AA | accounts | accounts with accounts type total exemption full |
| 2021-03-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-12-23 | AA | accounts | accounts with accounts type total exemption full |
| 2020-03-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-01-21 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2019-04-29 | AA01 | accounts | change account reference date company current extended |
| 2019-03-07 | CS01 | confirmation-statement | confirmation statement with updates |
| 2019-03-07 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2019-03-07 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
Credit score
Altman Z″ (private-firm) · reference 2025-03-31
-2.13
DISTRESS
Altman Z″
- Working capital / Total assets -0.407 × 6.56 = -2.67
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.058 × 6.72 = +0.39
- Book equity / Total liabilities 0.145 × 1.05 = +0.15
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
20.6
COLD
/ 100
- Filings velocity 17
- Capital events 0
- Officer churn 0
- Headcount trajectory 38
- Accounts trajectory 72
- 2 filing(s) in last 12 months
- Employees -12% YoY
- Turnover +22% YoY